The share of Russian drugs can grow to 70% in seven years in the Russian market
16 April 2024
The share of domestic drugs on the Russian market should increase to 70% in seven years. Russian Prime Minister Mikhail Mishustin said this when opening the government meeting.
Russia may increase number of scholarships for Indian medical students
16 April 2024
According to various estimates, today there are from 25 to 30 thousand students from India, including doctors, studying in Russia. For the most part, education is based on a commercial model, but the country also operates a quota system for free education. The current volume is 200 quotas, but in the future the number of scholarships may increase. Deputy Minister of Health of the Russian Federation Tatyana Semenova spoke about this.
Glucometer factory opened in Technopolis Moscow SEZ
15 April 2024
A resident of the special economic zone (SEZ) Technopolis Moscow – Elta – completed the construction of a plant for the production of medical equipment and consumables at the Alabushevo.
Russia approves clinical guidelines for managing adult spinal muscular atrophy
15 April 2024
In February 2024, the Ministry of Health of the Russian Federation approved clinical recommendations for the management of adult patients with spinal muscular atrophy (SMA). The document was adopted by the scientific and practical council of the department, the text of the recommendations was posted in the rubric of the Ministry of Health of the Russian Federation.
Production of an atraumatic wound-healing dressing began in the Moscow region
12 April 2024
The Evers company has registered a new medical product: an ointment mesh sterile dressing for wound healing. Production of this product has already commenced at the company’s facility, with a staggering target of manufacturing 40,000 units monthly.
Unique testing regimen could prevent nuclease contamination
12 April 2024
Biannual routine testing in the laboratory reduces both the likelihood of nuclease contamination occurrence and its impact, a study suggests.
First-in-class anaemia therapy granted expanded approval
11 April 2024
The expanded authorisation of Reblozyl is based on a Phase III trial which showed that the treatment nearly doubled the percentage of certain transfusion-dependent anaemia patients achieving haemoglobin increase, compared to epoetin alfa.
Two mental health centers will open in pilot mode in Moscow
11 April 2024
The Deputy Mayor of Moscow, Anastasia Rakova, has announced the upcoming opening of two mental health centers in the Russian capital, which will operate in experimental mode. “We have decided to open mental health centers in Moscow, where Muscovites will be offered comprehensive psychological and psychotherapeutic assistance,” she told reporters.
Antibody-immunotherapy treatment shows benefit in serious endometrial cancer
10 April 2024
The novel combination cancer therapy facilitated “exceptional” responses in some patients enrolled in a Phase II study for endometrial cancer.
mRNA therapy could provide intracellular protein replacement for rare disease
10 April 2024
With no treatments approved for propionic acidaemia, Moderna’s LNP-encapsulated mRNA therapy could offer a new therapeutic option for patients, new data suggests.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024